Literature DB >> 8242348

Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

V L Rao1, J F Giguère, G P Layrargues, R F Butterworth.   

Abstract

Using radioenzymatic assays, activities of MAOA and MAOB were measured in autopsied brain tissue from cirrhotic patients who died in hepatic coma and in material from an equal number of age-matched subjects who were free from hepatic, neurological or psychiatric disorders. Activities of both MAOA and MAOB were significantly increased in frontal cortex and caudate nucleus, two brain regions shown previously to be the site of functional and morphological alterations of astrocytes and increased concentrations of the acid metabolites of dopamine and serotonin. These findings suggest that increased monoamine metabolism and subsequent modifications of monoaminergic synaptic function could contribute to the pathogenesis of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242348     DOI: 10.1016/0006-8993(93)90126-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

Review 1.  Role of manganese in the pathogenesis of portal-systemic encephalopathy.

Authors:  G P Layrargues; C Rose; L Spahr; J Zayed; L Normandin; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 3.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 4.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

5.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

6.  Elevated serum levels of astroglial S100beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; M Otto; J Wildberg; E Bahn; H R Figulla; L Pralle; H Hartmann; E Rüther; G Ramadori
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

Review 7.  Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.

Authors:  R F Butterworth; L Spahr; S Fontaine; G P Layrargues
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

8.  Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy.

Authors:  V L Rao; G Therrien; R F Butterworth
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

9.  Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.

Authors:  M Bergeron; M S Swain; E Molina-Holgado; T A Reader; R F Butterworth
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

10.  Plasma and platelet serotonin levels in patients with liver cirrhosis.

Authors:  Dorde M Culafic; Dusko S Mirkovic; Miodrag D Vukcevic; Jelena S Rudic
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.